Lung Diseases, Rheumatoid Arthritis
Conditions
Keywords
Rheumatoid arthritis, Interstitial Lung Disease, RA, ILD
Brief summary
The purpose of this study is to investigate the link between the lungs and rheumatoid arthritis (RA). Additionally, to understand why RA patients get lung disease, how to treat, and prevent the disease.
Detailed description
This study is to learn more about the risk factors for the development of lung disease among patients with rheumatoid arthritis (RA), an auto-immune disease. Additionally, those at heightened risk of developing RA such as in the pre-RA period. This is a prospective and retrospective study, which 420 patients will be enrolled into the study. In-person participation will be up to 4 years, completing different standard of care assessments yearly. Additionally, quality of life questionnaires will be completed every 6 months at 4 time points. Lastly, an extended follow-up will be performed yearly for an additional 6 years, an overall 10 year participation.
Interventions
None listed
Sponsors
Pfizer
National Jewish Health
Study design
Observational model
OTHER
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Inclusion criteria
1\. Age 18 - 80 years
Exclusion criteria
1. Subjects who do not speak English 2. Subjects without the capacity to sign the informed consent form (ICF) 3. Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Define which patients with RA (or pre-RA) are at greatest risk for developing RA-related lung disease (LD). | 10 years |
Countries
United States
Contacts
Primary ContactFaduma Ahmed, MPH
Backup ContactJami Henriksen
Outcome results
None listed